Home

Reinig de vloer Belangrijk nieuws surfen teva production facilities vezel afstand Plakken

Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters

New York jury holds drug firm Teva liable in opioid crisis
New York jury holds drug firm Teva liable in opioid crisis

Teva says it's in talks with COVID vaccine makers to help produce shots |  The Times of Israel
Teva says it's in talks with COVID vaccine makers to help produce shots | The Times of Israel

Anything but Generic: A map for Selling to Teva Pharmaceuticals
Anything but Generic: A map for Selling to Teva Pharmaceuticals

Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals - Wikipedia

Teva's recall of U.S.-made drugs latest example of contamination fears in  generic marketplace; report says Lilly, Pfizer and former Mylan plant in  Morgantown have been cited in the past | WV News | wvnews.com
Teva's recall of U.S.-made drugs latest example of contamination fears in generic marketplace; report says Lilly, Pfizer and former Mylan plant in Morgantown have been cited in the past | WV News | wvnews.com

Teva Selling Jerusalem Land Tenure Rights Ahead of Factory Closures | Ctech
Teva Selling Jerusalem Land Tenure Rights Ahead of Factory Closures | Ctech

Taiyo Pharmaceutical Industry, Contract Manufacturing Plant -  Pharmaceutical Technology
Taiyo Pharmaceutical Industry, Contract Manufacturing Plant - Pharmaceutical Technology

Teva to cut 14,000 jobs | Business | Chemistry World
Teva to cut 14,000 jobs | Business | Chemistry World

Teva says vaccine makers have not taken its offer to help produce jabs |  Financial Times
Teva says vaccine makers have not taken its offer to help produce jabs | Financial Times

Teva Recalls U.S.-Made Drugs Following Contamination Fears
Teva Recalls U.S.-Made Drugs Following Contamination Fears

Teva timeline: CEO says 20-25 manufacturing plants to close in next two  years
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years

Teva sells its only manufacturing plant in Russia
Teva sells its only manufacturing plant in Russia

Teva: 'Celltrion deal will double biosimilar sales to $600m'
Teva: 'Celltrion deal will double biosimilar sales to $600m'

Case Study: SRP with Desiccant Feeding maximizes efficiency in minimal  space — Omega Design Corporation - Trusted Expertise in Packaging  Automation and Container Handling Equipment
Case Study: SRP with Desiccant Feeding maximizes efficiency in minimal space — Omega Design Corporation - Trusted Expertise in Packaging Automation and Container Handling Equipment

Teva Pharmaceutical CEO says health-care is facing 'huge disruption'
Teva Pharmaceutical CEO says health-care is facing 'huge disruption'

Teva's 70+ manufacturing sites could be halved in efficiency drive
Teva's 70+ manufacturing sites could be halved in efficiency drive

Troubled Teva plant in Hungary faces an FDA crackdown - STAT
Troubled Teva plant in Hungary faces an FDA crackdown - STAT

Teva Recalls U.S.-Made Drugs Following Contamination Fears - Bloomberg
Teva Recalls U.S.-Made Drugs Following Contamination Fears - Bloomberg

Flamma gains a North American foothold near Philadelphia
Flamma gains a North American foothold near Philadelphia

Teva plans the large-scale production of monoclonal antibodies in Ulm -  Healthcare industry
Teva plans the large-scale production of monoclonal antibodies in Ulm - Healthcare industry

Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg

Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility |  2018-10-16 | Engineering News-Record
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record

Teva Pharmaceuticals to narrow focus on drugs, trim costs
Teva Pharmaceuticals to narrow focus on drugs, trim costs

Teva Pharmaceutical Industries is in talks to manufacture and distribute  COVID vaccines | Fortune
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune